| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/27/2009 | WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | WO2009104990A1 2,4-diaminopyridine derivatives, a pharmaceutical composition and a medicinal agent which are based thereon and used for treating or preventing diseases and disturbances caused by the hyperactivation of nmda-receptors and/or in the form of cognitive function stimulators and a method for the use thereof |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | WO2009104520A1 Method for producing phenoxypyridine derivative |
| 08/27/2009 | WO2009103966A1 Bicyclylaryl-aryl-amine compounds and their use |
| 08/27/2009 | WO2009103652A1 Modulators for amyloid beta |
| 08/27/2009 | WO2009103650A1 Sulfonamide compounds and their use as fungicide |
| 08/27/2009 | WO2009103552A1 Substituted indole derivatives |
| 08/27/2009 | WO2009103478A1 Pyridone and pyridazinone derivatives as mch antagonists |
| 08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009086028A3 Carbazole-containing materials in phosphorescent light emitting diodes |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009076200A3 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2009075504A3 Crystalline form of bepotastine p-toluenesulfonate, method for preparing same and pharmaceutical composition containing same |
| 08/27/2009 | WO2009064388A3 Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders |
| 08/27/2009 | WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/27/2009 | US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215829 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 08/27/2009 | US20090215826 Solid forms of a pyrrolidine-3,4-dicarboxamide derivative |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215824 Indazole derivatives as inhibitors of hormone sensitive lipase |
| 08/27/2009 | US20090215821 N-Substituted Azacycles |
| 08/27/2009 | US20090215815 Neurotrophin antagonist compositions |
| 08/27/2009 | US20090215799 Heterocyclic substituted bisarylurea derivatives |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215790 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof |
| 08/27/2009 | US20090215789 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals |
| 08/27/2009 | US20090215783 Composition for induction or inhibition of stem cell differentiation |
| 08/27/2009 | US20090215776 Organic compounds |
| 08/27/2009 | US20090215772 Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 08/27/2009 | US20090215770 Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases |
| 08/27/2009 | US20090215764 Antimicrobial agents |
| 08/27/2009 | US20090215759 Modulators for amyloid beta |
| 08/27/2009 | US20090215728 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/27/2009 | US20090215705 Alpha 7 Nicotinic Receptor Selective Ligands |
| 08/27/2009 | US20090211038 Hemicyanin styryl thiol/disulfide dye, composition comprising hemicyanin styryl thiol/disulfide dye, and method for lightening keratin materials using hemicyanin styryl thiol/disulfide dye |
| 08/27/2009 | CA2716515A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | CA2716332A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2716270A1 Substituted indole derivatives |
| 08/27/2009 | CA2715872A1 Benzodiazepine compound and pharmaceutical composition |
| 08/27/2009 | CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 08/27/2009 | CA2714215A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | CA2714122A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 08/27/2009 | CA2713716A1 Modulators for amyloid beta |
| 08/26/2009 | EP2093223A1 Process for production of anthranilamide compound |
| 08/26/2009 | EP2091946A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases |
| 08/26/2009 | EP2091945A1 Novel inhibitors of glutaminyl cyclase |
| 08/26/2009 | EP2091944A2 Substituted bicyclocarboxyamide compounds |
| 08/26/2009 | EP2091943A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors |
| 08/26/2009 | EP2091942A1 Substituted pyrazinone derivatives for use as a medicine |
| 08/26/2009 | EP2091941A2 Mapk/erk kinase inhibitors |
| 08/26/2009 | EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 08/26/2009 | EP2091939A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 08/26/2009 | EP2091938A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 08/26/2009 | EP2091937A2 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 08/26/2009 | EP2091936A1 Therapeutic agents useful for treating pain |
| 08/26/2009 | EP2091927A1 Thiazole and oxazole-substituted arylamides |
| 08/26/2009 | EP2091926A1 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 08/26/2009 | EP2091924A1 Pyrimidine derivatives and their use as pesticides |
| 08/26/2009 | EP2091922A2 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 08/26/2009 | EP2091919A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer |
| 08/26/2009 | EP2091918A2 Compounds and compositions as protein kinase inhibitors |
| 08/26/2009 | EP2091916A2 L-phenylalanine derivatives and their use as integrin antagonists |
| 08/26/2009 | EP2091534A1 Azetidinone derivatives and methods of use thereof |
| 08/26/2009 | EP1819693B1 Antithrombotic diamides |
| 08/26/2009 | EP1783116B1 2-phenylpyridine derivative |
| 08/26/2009 | EP1773817B1 Substituted aryl-amine derivatives and methods of use |
| 08/26/2009 | EP1745033A4 4,5-disubstituted-2-aryl pyrimidines |
| 08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 08/26/2009 | EP1603899B1 Heterocyclic urea derivatives for the treatment of pain |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1539700B1 8-hydroxy quinoline derivatives |
| 08/26/2009 | CN101516874A Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 08/26/2009 | CN101516873A Indazolyl derivatives useful as potassium channel modulating agents |
| 08/26/2009 | CN101516872A Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 08/26/2009 | CN101516871A Novel pyridazine derivatives |
| 08/26/2009 | CN101516870A Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 08/26/2009 | CN101516869A Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 08/26/2009 | CN101516868A Novel pyridazine derivatives |
| 08/26/2009 | CN101516867A Aryl sulfonamides with an analgesic action |
| 08/26/2009 | CN101516853A Quinolinone derivatives |
| 08/26/2009 | CN101516852A Quinoline derivatives with 5-HT-binding properties |
| 08/26/2009 | CN101516849A 5-phenyl-nicotinamide derivatives |
| 08/26/2009 | CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 08/26/2009 | CN101516366A Oxindole derivatives as anticancer agents |
| 08/26/2009 | CN101516335A Formulations for benzimidazolyl pyridyl ethers |
| 08/26/2009 | CN101514199A Compound of Lansoprazole and a preparation method thereof |
| 08/26/2009 | CN101514198A Compound of pantoprazole sodium and a preparation method thereof |
| 08/26/2009 | CN101514197A Novel method for preparing benzimidazole proton pump inhibitors |
| 08/26/2009 | CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 08/26/2009 | CN101513402A Antiviral agent |
| 08/26/2009 | CN100532376C Use of alkaloid for preparing antineoplastic medicine |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |